- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-27-0007662

About Goldlan Pharmaceuticals LLP
Data last updated:
Goldlan Pharmaceuticals LLP is a limited liability partnership (LLP) based in Navi Mumbai, Maharashtra, India. It operates in the petrochemicals and derivatives segment of the chemicals and materials sector. It was incorporated on 05 July 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAJ-9008. Its GSTIN is 27AARFG4077G1Z0 (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Madhavi Moreshwar Jadhav and Pradyumn Shrikrishnarao Rangacharya.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Fl – 501 M/S Neev Buil. & Dev. Pl – 150 Sec 10 Taloja Panchnand, Navi Mumbai, Maharashtra, India – 410206.
As per MCA filings, the LLP has open charges of ₹18 Lakh on record.
Goldlan Pharmaceuticals LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0007662). For more details, the LLP can be reached via its website goldlanpharma.com.
Recognitions & Rankings of Goldlan Pharmaceuticals
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFl – 501 M/S Neev Buil. & Dev. Pl – 150 Sec 10 Taloja Panchnand, Navi Mumbai, Maharashtra, India – 410206
- IndustryChemicals and Materials, Petrochemicals & Derivatives
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Goldlan Pharmaceuticals LLP FY 2024 filings available
Financial Statement Summary of Goldlan Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Goldlan Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Goldlan Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Goldlan Pharmaceuticals LLP
Goldlan Pharmaceuticals has 2 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhavi Moreshwar Jadhav | Designated Partner | 05 Jul 2017 | 9 Years 3 Months | Current |
| Pradyumn Shrikrishnarao Rangacharya | Designated Partner | 05 Jul 2017 | 9 Years 3 Months | Current |
Charges & Borrowings of Goldlan Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2021 | State Bank of India | ₹18 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Goldlan Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Goldlan Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Goldlan Pharmaceuticals LLP
Goldlan Pharmaceuticals LLP has 6 designated partner changes on record since 2017: 4 appointments and 2 cessations. The latest: Archana Rahul Patil ceased to be Designated Partner on 04 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for Goldlan Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Goldlan Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Goldlan Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Goldlan Pharmaceuticals LLP
Goldlan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARFG4077G1Z0 | Maharashtra | Active | 06 Oct 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Goldlan Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Goldlan Pharmaceuticals LLP
Goldlan Pharmaceuticals is an active limited liability partnership based in Navi Mumbai, Maharashtra, India. The LLP works in petrochemicals and derivatives, within the chemicals and materials industry. It was incorporated on 05 July 2017 (9+ years old) and is registered under LLPIN AAJ-9008.
Goldlan Pharmaceuticals has 2 current designated partners:
- Madhavi Moreshwar Jadhav - Designated Partner
- Pradyumn Shrikrishnarao Rangacharya - Designated Partner
The GSTIN of Goldlan Pharmaceuticals is 27AARFG4077G1Z0, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Goldlan Pharmaceuticals is AAJ-9008. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Goldlan Pharmaceuticals was incorporated on 05 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Archana Rahul Patil ceased to be Designated Partner on 04 Mar 2019. Moreshwar Dhondo Jadhav was appointed as Partner on 04 Mar 2019. Rahul Kisan Patil ceased to be Designated Partner on 04 Mar 2019. Goldlan Pharmaceuticals has 6 designated partner changes on record in total.
Yes, Goldlan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0007662).
Goldlan Pharmaceuticals can be reached through the website goldlanpharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Goldlan Pharmaceuticals is at Fl – 501 MS Neev Buil. & Dev. Pl – 150 Sec 10 Taloja Panchnand, Navi Mumbai, Maharashtra, India – 410206.
The total obligation of contribution is ₹1 Lakh.